SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 76391.39
363.66 (-0.47%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
1	Nectar Lifesciences Ltd.	Q V PT	204 Small Cap	10.48 (-0.10%)	N/A	0.35	-6.71	-232.05	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Fabtech Technologies Ltd.	Q V PT	654 Small Cap	148.85 (1.22%)	27.28	1.7	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Anuh Pharma Ltd.	Q V+ PT	810 Small Cap	79.16 (-2.02%)	19.33	2.25	16.60	20.73	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Shree Ganesh Remedies Ltd.	Q V PT	845 Small Cap	660.10 (0.32%)	47.68	5.2	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Kopran Ltd.	Q V PT	975 Small Cap	200.50 (-0.67%)	31.85	2.16	8.61	14.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Sigachi Industries Ltd.	Q V+ PT	1,011 Small Cap	25.94 (-1.97%)	N/A	2.08	24.05	7.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Themis Medicare Ltd.	Q V PT	997 Small Cap	107.95 (-0.32%)	N/A	3.7	15.00	7.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Gujarat Kidney And Super Speciality Ltd.	Q V+ PT	1,004 Small Cap	127.25 (-0.12%)	101.33	4.07	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Health X Platform Ltd.	Q V PT	1,034 Small Cap	318.15 (-2.17%)	N/A	3.74	109.54	-201.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Bajaj Healthcare Ltd.	Q V PT	1,087 Small Cap	317.90 (-1.59%)	46.48	1.96	5.76	2.91	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	3B Blackbio Dx Ltd.	Q V PT	1,105 Small Cap	1,272.70 (-1.16%)	22.15	4	46.29	132.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Wanbury Ltd.	Q V+ PT	1,155 Small Cap	329.85 (-0.20%)	17.43	7.98	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Lincoln Pharmaceuticals Ltd.	Q V PT	1,160 Small Cap	589.25 (1.77%)	13.43	1.56	10.63	11.62	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Fermenta Biotech Ltd.	Q V PT	1,239 Small Cap	401.95 (-4.49%)	18.4	2.8	7.46	0.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Laxmi Dental Ltd.	Q V PT	1,200 Small Cap	215.45 (-1.28%)	72.09	4.79	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Syncom Formulations (India) Ltd.	Q V PT	1,239 Small Cap	13.13 (-0.38%)	16.24	2.99	17.63	21.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	GPT Healthcare Ltd.	Q V PT	1,273 Small Cap	156.50 (0.87%)	30.42	4.77	14.25	6.47	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Suraksha Diagnostic Ltd.	Q V PT	1,354 Small Cap	263.70 (1.42%)	42.67	5.61	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,450 Small Cap	217.85 (-0.95%)	33.34	6.05	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Tarsons Products Ltd.	Q V+ PT	1,636 Small Cap	315.85 (2.70%)	74.17	2.49	12.30	-1.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Krsnaa Diagnostics Ltd.	Q V+ PT	1,751 Small Cap	537.10 (-0.47%)	17.18	1.78	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Shalby Ltd.	Q V+ PT	1,763 Small Cap	163 (-0.15%)	15.59	1.41	12.52	25.39	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Windlas Biotech Ltd.	Q V PT	1,790 Small Cap	859.35 (-0.91%)	26.69	3.45	16.15	15.34	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Hester Biosciences Ltd.	Q V PT	2,067 Small Cap	2,363.55 (-2.70%)	38.59	5.22	6.98	0.80	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	KMC Speciality Hospitals (India) Ltd.	Q V PT	2,161 Small Cap	129.20 (-2.49%)	N/A	N/A	19.21	12.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Indoco Remedies Ltd.	Q V+ PT	2,154 Small Cap	237.55 (1.78%)	N/A	1.99	6.54	-182.78	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,421 Small Cap	5,030.05 (0.40%)	34.68	7.02	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Vimta Labs Ltd.	Q V+ PT	2,609 Small Cap	563.20 (-3.55%)	31.59	5.35	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Solara Active Pharma Sciences Ltd.	Q V PT	2,583 Small Cap	524.10 (-2.12%)	N/A	2.01	-0.58	-134.64	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Fischer Medical Ventures Ltd.	Q V PT	2,553 Small Cap	38.92 (-0.21%)	N/A	8.16	96.10	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Rubicon Research	1,531.10	4.52%
Bliss GVS Pharma	462.85	3.28%
Tarsons Products	315.85	2.70%
Marksans Pharma	246.50	2.32%
Piramal Pharma	180.85	2.15%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Acutaas Chemicals	3,455.90	-5.77%
Fermenta Biotech	401.95	-4.49%
Orchid Pharma	963	-3.84%
Cohance Lifesciences	422.40	-3.77%
Dishman Carbogen Amc	179.45	-3.70%

News about Top Pharma Companies in India

Jul, 2026

Gujarat Kidney and Super Specialty submit notice of postal ballot.

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Kidney and Super Specialty has enclosed the clippings of newspaper publication in respect of the Notice of Postal Ballot, published in the following newspapers on Thursday, July 23, 2026: The Financial Express-English (Ahmedabad edition); Gujarat Mitra- Gujarati (Vadodara Edition).

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Wanbury informs about updates

Further to its letter dated 20th July, 2026, Wanbury has informed that a routine current Good Manufacturing Practices (cGMP) inspection was conducted by the United States Food and Drug Administration (USFDA) at the company's facility at Tanuku, West Godavari District, Andra Pradesh during the period from July 13, 2026 to July 17, 2026. At the conclusion of the inspection, the USFDA has issued a Form 483 with six observations. The Company will respond to these observations to FDA within the stipulated time. The relevant disclosures as required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular HO/ 49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 are provided in Annexure - I.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Sigachi Industries submits board meeting intimation

Sigachi Industries has informed that pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the meeting of the Board of Directors of the Company is scheduled to be held on Monday, July 27, 2026 through Video Conference to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended June 30, 2026; and any other business with the permission of the Chair.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Hester Biosciences informs about outcome of AGM

Hester Biosciences has informed that this is in reference to letter dated 18 June 2026 and 8 July 2026, the 39th Annual General Meeting (AGM) was held on Tuesday, 21 July 2026 through Video Conferencing (VC) / Other Audio Visual Means (OAVM), commenced at 10:32 am and concluded at 11:08 am, in accordance with the circular(s) issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India and the businesses transacted at the Annual General Meeting mentioned in the Notice dated 15 May 2026. All the resolutions placed before the members for their approval have been passed with the requisite majority via electronic voting as per the scrutiniser's report dated 21 July 2026. They attached proceedings of the 39th Annual General Meeting of the Company; Voting results of 39th Annual General Meeting of the Company; and Scrutiniser's Report on of 39th Annual General Meeting held on 21 July 2026.

The above information is a part of company's filings submitted to BSE.

Jul, 2026

Themis Medicare informs about revised disclosure

Themis Medicare has informed that it enclosed revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 20, 2026 for Vividhmargi Investments.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

USFDA conducts cGMP inspection at Wanbury’s Andhra Pradesh facility

At the conclusion of the inspection, the USFDA has issued a Form 483 with six observations

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Nectar Lifesciences Ltd.	204 Crore
2	Fabtech Technologies Ltd.	654 Crore
3	Anuh Pharma Ltd.	810 Crore
4	Shree Ganesh Remedies Ltd.	845 Crore
5	Kopran Ltd.	975 Crore
6	Sigachi Industries Ltd.	1,011 Crore
7	Themis Medicare Ltd.	997 Crore
8	Gujarat Kidney And Super Speciality Ltd.	1,004 Crore
9	Health X Platform Ltd.	1,034 Crore
10	Bajaj Healthcare Ltd.	1,087 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	28,735	61,408	39.57	12.93	27.13	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	5,066	1,91,530	88.53	22.78	45.95	29.04
Lupin Ltd. (M)	Somewhat Good	2,396	1,10,002	20.63	4.91	11.93	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,441	43,218	40.93	9.55	27.65	25.35
Alkem Laboratories Ltd. (M)	Very Good	5,607	66,822	30.58	4.77	22.18	17.86

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,568	85,232	90.72
Sai Life Sciences Ltd. (S)	Very Good	1,240	26,541	51.95
Torrent Pharmaceuticals Ltd. (L)	Very Good	5,066	1,91,530	42.54
Aurobindo Pharma Ltd. (M)	Very Good	1,524	88,203	36.43
Ajanta Pharma Ltd. (M)	Very Good	3,441	43,218	26.65
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Very Good	1,240	26,541	77.72	10.58	40.87	17.75
Ajanta Pharma Ltd. (M)	Very Good	3,441	43,218	40.93	9.55	27.65	13.54
Mankind Pharma Ltd. (M)	Very Good	2,557	1,05,068	51.57	6.43	32.30	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,114	1,12,693	22.36	4.33	13.70	13.52
Lupin Ltd. (M)	Somewhat Good	2,396	1,10,002	20.63	4.91	11.93	13.02

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Lupin Ltd. (M)	Somewhat Good	2,396	1,10,002	20.63	4.91	11.93	32.37
Abbott India Ltd. (M)	Very Good	28,735	61,408	39.57	12.93	27.13	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,167	98,742	30.64	2.62	15.71	15.75
Zydus Lifesciences Ltd. (M)	Very Good	1,114	1,12,693	22.36	4.33	13.70	14.72
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,954	4,66,179	40.61	5.58	23.28	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Gujarat Kidney and Super Specialty submit notice of postal ballot.

Wanbury informs about updates

Sigachi Industries submits board meeting intimation

Hester Biosciences informs about outcome of AGM

Themis Medicare informs about revised disclosure

USFDA conducts cGMP inspection at Wanbury’s Andhra Pradesh facility

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.